Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Actimorph
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Actimorph 5mg orodispersible tablets
0407020Q0BQAFGJ
|
Actimorph | Morphine sulfate | Central Nervous System | 1,306 |
|
Actimorph 2.5mg orodispersible tablets
0407020Q0BQAAGE
|
Actimorph | Morphine sulfate | Central Nervous System | 1,043 |
|
Actimorph 10mg orodispersible tablets
0407020Q0BQABGF
|
Actimorph | Morphine sulfate | Central Nervous System | 766 |
|
Actimorph 1mg orodispersible tablets
0407020Q0BQACGG
|
Actimorph | Morphine sulfate | Central Nervous System | 171 |
|
Actimorph 20mg orodispersible tablets
0407020Q0BQADGH
|
Actimorph | Morphine sulfate | Central Nervous System | 136 |
|
Actimorph 30mg orodispersible tablets
0407020Q0BQAEGI
|
Actimorph | Morphine sulfate | Central Nervous System | 35 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.